The US government temporarily resumed providing HIV medications globally, preventing a major health setback.
This crucial decision, following a suspension of aid, safeguards millions relying on PEPFAR programs.
Although the long-term future of the program remains unclear, this reprieve provides lifesaving support.
Experts warn that without permanent funding, a devastating resurgence of HIV infections is very likely.